PresolicitationActive75N98026Q00590
Agilent NovoCyte Advanteon Flow Cytometer
HEALTH AND HUMAN SERVICES, DEPARTMENT OF / NATIONAL INSTITUTES OF HEALTH / NATIONAL INSTITUTES OF HEALTH OLAOKey dates?
- Posted?
- Jun 10, 2026
- Response deadline?
- Jun 22, 2026, 1:00 PM UTC
- Archive date?
- —
- Archive type?
- auto15
Classification?
- Notice type?
- Presolicitation
- Base type?
- Presolicitation
- Set-aside?
- No Set aside used
- Set-aside code?
- NONE
- PSC?
- 6640
NAICS?
Issuing office?
- Department?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Sub-tier?
- NATIONAL INSTITUTES OF HEALTH
- Office?
- NATIONAL INSTITUTES OF HEALTH OLAO
- Office code?
- 075.7529.75N980
- Organization type?
- OFFICE
- Office address?
- BETHESDA, MD, 20892, USA
Place of performance?
- Street?
- —
- Street 2?
- —
- City?
- Bethesda
- State?
- Maryland
- Zip?
- 20892
- Country?
- UNITED STATES
Contacts?
- LAW, JAMES Bprimary
Description?
The NovoCyte Advanteon Flow Cytometer is a benchtop system designed for high-parameter cellular analysis in research and clinical laboratory settings. It is an advanced platform for multicolor flow cytometry that combines flexible hardware configurations with automated data acquisition and analysis capabilities. The Section on Regulatory Ribonucleic Acids conducts research on the regulation of gene expression by ribonucleic acid binding proteins and micro ribonucleic acids. These studies are critical to understanding how gene regulation is disrupted in diseases such as cancer, hearing loss, and diabetes. Understanding these processes supports the development of new therapeutic approaches. Acquisition of the NovoCyte Advanteon Flow Cytometer will significantly increase experimental throughput and improve the efficiency of research workflows supporting these projects.
Similar open contracts
Metadata?
- Notice ID?
- eee2f699f0724013ba30903f8399b100
- Full path?
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF.NATIONAL INSTITUTES OF HEALTH.NATIONAL INSTITUTES OF HEALTH OLAO
- Office code?
- 075.7529.75N980
- Ingested?
- Jun 11, 2026
- Updated?
- Jul 7, 2026